Sparine (promazine) is a small molecule pharmaceutical. Promazine was first approved as Sparine on 1982-01-01. It is used to treat nausea, psychotic disorders, schizophrenia, and vomiting in the USA. The pharmaceutical is active against D(2) dopamine receptor and D(3) dopamine receptor. In addition, it is known to target major prion protein.
|Indication||nausea, psychotic disorders, schizophrenia, vomiting|
|Drug Class||Typical antipsychotic|